Last reviewed · How we verify
Erector Spinae nerve block
At a glance
| Generic name | Erector Spinae nerve block |
|---|---|
| Sponsor | Charles Luke |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Sacral ESP Block and Dorsal Penile Nerve Block in Pediatric Hypospadias Surgery (NA)
- Rhomboid Intercostal Block vs Erector Spinae Block (NA)
- Erector Spinae Plane Block for Acute Back Pain in the Emergency Department (NA)
- Comparison of Pericapsular Nerve Group+ Lateral Femoral Cutaneous Nerve Block Versus Lumbar Erector Spinae Plane Block in Hip Arthroplasty Surgery
- Subcostal Transversus Abdominus , Erector Spinae and Paravertebral Blocks Effects on Laparoscopic Cholecystectomy Cases (NA)
- PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery (NA)
- Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia (NA)
- ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Erector Spinae nerve block CI brief — competitive landscape report
- Erector Spinae nerve block updates RSS · CI watch RSS
- Charles Luke portfolio CI